Activation of nuclear factor-kappa B by linear ubiquitin chain assembly complex contributes to lung metastasis of osteosarcoma cells

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 409-417

  Tomonaga, Masato ^a   Hashimoto, Nobuyuki ^a   Tokunaga, Fuminori ^a   Onishi, Megumi ^a   Myoui, Akira ^a   Yoshikawa, Hideki ^a   Iwai, Kazuhiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Linear ubiquitin chain assembly complex; Lung metastasis; Nuclear factor kappa B; Osteosarcoma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; FEMALE; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; LUCIFERASES; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; OSTEOSARCOMA; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 84855695046     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1209     Document Type: Article

References (42)

1. Goorin AM, Schwartzentruber DJ, Devidas M, et al: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21: 1574-1580, 2003. (Pubitemid 46594112)
2. Ferrari S, Smeland S, Mercuri M, et al: Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23: 8845-8852, 2005. (Pubitemid 46211531)
3. Bacci G, Rocca M, Salone M, et al: High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 98: 415-420, 2008.
4. Kager L, Zoubek A, Potschger U, et al: Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21: 2011-2018, 2003. (Pubitemid 46606391)
5. Asai T, Ueda T, Itoh K, et al: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76: 418-422, 1998. (Pubitemid 28282943)
6. Asai T, Tomita Y, Nakatsuka S, et al: VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 93: 296-304, 2002. (Pubitemid 34464366)
7. Nishimura A, Akeda K, Matsubara T, et al: Transfection of NF-kappa B decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma. Gene Ther 18: 250-259, 2011.
8. Kishida Y, Yoshikawa H and Myoui A: Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res 13: 59-67, 2007. (Pubitemid 46121853)
9. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
10. Philip S, Bulbule A and Kundu GC: Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 276: 44926-44935, 2001.
11. Chilov D, Kukk E, Taira S, et al: Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272: 25176-25183, 1997. (Pubitemid 27415703)
12. Caldenhoven E, Coffer P, Yuan J, et al: Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J Biol Chem 269: 21146-21154, 1994. (Pubitemid 24266488)
13. Lenz G, Davis RE, Ngo VN, et al: Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319: 1676-1679, 2008. (Pubitemid 351432507)
14. Wilson W III and Baldwin AS: Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. Cancer Res 68: 8156-8163, 2008.
15. Tai DI, Tsai SL, Chang YH, et al: Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89: 2274-2281, 2000.
16. Kato T Jr, Gotoh Y, Hoffmann A and Ono Y: Negative regulation of constitutive NF-kappaB and JNK signaling by PKN1-mediated phosphorylation of TRAF1. Genes Cells 13: 509-520, 2008. (Pubitemid 351567051)
17. Dhawan P, Su Y, Thu YM, et al: The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem 283: 15399-15408, 2008.
18. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ and Sonenshein GE: Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287-1299, 2001. (Pubitemid 32269934)
19. Tokunaga F, Sakata S, Saeki Y, et al: Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11: 123-132, 2009.
20. Tokunaga F, Nakagawa T, Nakahara M, et al: SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471: 633-636, 2011.
21. Gerlach B, Cordier SM, Schmukle AC, et al: Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471: 591-596, 2011.
22. Xia T, Liang Y, Ma J, Li M, Gong M and Yu X: Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Endocrine 39: 104-112, 2011.
23. Liang Y, Seymour RE and Sundberg JP: Inhibition of NF-kappaB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. J Invest Dermatol 131: 141-149, 2011.
24. Yui Y, Itoh K, Yoshioka K, et al: Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8. Clin Exp Metastasis 27: 619-630, 2010.
25. Kirisako T, Kamei K, Murata S, et al: A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 25: 4877-4887, 2006. (Pubitemid 44607032)
26. Radjabi AR, Sawada K, Jagadeeswaran S, et al: Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface. J Biol Chem 283: 2822-2834, 2008.
27. Kahari VM and Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31: 34-45, 1999.
28. Shima I, Sasaguri Y, Kusukawa J, et al: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 70: 2747-2753, 1992.
29. Pazzaglia L, Ponticelli F, Magagnoli G, et al: Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness. Anticancer Res 24: 967-972, 2004. (Pubitemid 38625046)
30. Huang WC, Chan ST, Yang TL, Tzeng CC and Chen CC: Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma- butyrolactone derivatives. Carcinogenesis 25: 1925-1934, 2004.
31. Lin YC, Shun CT, Wu MS and Chen CC: A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res 12: 7165-7173, 2006.
32. Kobayashi H, Boelte KC and Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 14: 377-386, 2007.
33. Christiansen I, Gidlof C, Wallgren AC, Simonsson B and Totterman TH: Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood 84: 3010-3016, 1994. (Pubitemid 24328092)
34. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ and Rothlein R: Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 51: 5003-5005, 1991.
35. Toiyama Y, Miki C, Inoue Y, et al: Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients. Ann Surg Oncol 15: 1617-1624, 2008.
36. Maruo Y, Gochi A, Kaihara A, et al: ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer 100: 486-490, 2002.
37. Liang S, Fu C, Wagner D, et al: Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. Am J Physiol Cell Physiol 294: C743-C753, 2008. (Pubitemid 351468702)
38. Huh SJ, Liang S, Sharma A, Dong C and Robertson GP: Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 70: 6071-6082, 2010.
39. Rosette C, Roth RB, Oeth P, et al: Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26: 943-950, 2005. (Pubitemid 41214323)
40. Yang YM, Du GJ and Lin HH: Experimental study of thalidomide for treatment of murine hepatocellular carcinoma. Di Yi Jun Yi Da Xue Xue Bao 25: 925-928, 2005.
41. Ten Kate M, Hofland LJ, van Grevenstein WMU, van Koetsveld PV, Jeekel J and van Eijck CHJ: Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium. Int J Cancer 112: 943-950, 2004. (Pubitemid 39506999)
42. Jung J, Kim JM, Park B, et al: Newly identified tumor-associated role of human Sharpin. Mol Cell Biochem 340: 161-167, 2010.